Related Experiment Video

Updated: Sep 11, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

[Regulation of the cell cycle and the development of cancer: therapeutic prospects]

O Peralta-Zaragoza1, M Bahena-Román, C E Díaz-Benítez

  • 1Centro de Investigación sobre Enfermedades Infecciosas, Instituto Nacional de Salud Pública, México.

Salud Publica De Mexico
|January 10, 1998
PubMed

Insights

Cancer cells acquire genetic alterations, disrupting DNA replication and repair. Understanding these cell cycle disruptions offers new therapeutic targets for cancer treatment.

Area of Science:

  • Molecular Biology
  • Genetics
  • Cell Biology

Context:

  • Cancer development involves genetic alterations leading to loss of DNA replication, repair, and segregation fidelity.
  • Tumor cells activate escape pathways, overriding normal cellular defense mechanisms against cancer progression.
  • Recent research focuses on identifying etiological factors driving cancer development.

Purpose:

  • To explore the molecular mechanisms underlying cellular transformation from normal to tumor cells.
  • To investigate how disruptions in cell cycle regulation contribute to cancer progression.
  • To identify potential therapeutic targets based on molecular insights into cancer development.

Summary:

  • Genetic alterations, including errors in DNA replication, repair, and segregation, are crucial in normal cells transforming into tumor cells.
  • The cell cycle, regulated by cyclin-dependent kinases, checkpoints, and repair pathways, is often dysregulated in cancer.
  • Specific genetic changes can abrogate the coordinated functions within the cell cycle, promoting tumor progression.

Impact:

  • Understanding these molecular mechanisms provides insights into cancer etiology.
  • Identifying abrogation points in cell cycle regulation can lead to the development of novel cancer therapies.
  • This research highlights the potential for targeted therapies based on the molecular underpinnings of cellular transformation.

More Related Videos

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols12:02

Studying Cell Cycle-regulated Gene Expression by Two Complementary Cell Synchronization Protocols

Published on: June 6, 2017

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Molecular Factors Affecting Cell Division01:27

Molecular Factors Affecting Cell Division

Several external and internal factors influence the initiation and inhibition of cell division. For instance, the death of nearby cells or the release of human growth hormone (hGH) promotes cell division. In contrast, lack of hGH or crowding of cells can inhibit cell division.
Several proteins function as internal regulators to ensure each cell cycle stage is completed faithfully before proceeding to the next. Regulator molecules may act directly or influence the activity or production of other...